Page 10 - COVID-19-Mortality-review-in-Malaysia-and-updates-on-clinical-management-of-COVID-19
P. 10
coming forward. Are you aware of any studies which compare these two drugs head-
to-head?
10. Are patients on Disease-modifying anti-rheumatic drugs (DMARDs) and long term
steroids less likely to get cytokine release syndrome?
11. What are the mortality numbers involving healthcare workers?
12. Are we going to use convalescent plasma in Malaysia?
13. Can you update us on the sequencing of the virus strains? Were there mutations?
Will it affect the pick up rate of RT-PCR? Any updates from the Institute for Medical
Research (IMR)?
14. What are the common pitfalls that we picked up from the mortality review?
15. Could you comment on the false positives on RT-PCR testing?
“Wrap Up Message” by Datuk Dr Christopher Lee
Speakers’ Brief Bio
